Return to program book search

Session Information

CRS C016 - Translating Evidence into Practice: Psoriasis Guidelines

Tuition fee and ticket required for admission

Subject:

Date: Sunday, March 23

CME Credits: 3.00

Location: Room 107/109/111/113

Time: 2:00 PM - 5:00 PM

Director: Alan Menter, MD, FAAD

Speakers:
  • Steven R. Feldman, MD, PhD, FAAD
  • Alice B. Gottlieb, MD, PhD, FAAD - Handout
  • Mark Lebwohl, MD, FAAD - Handout
  • Craig L. Leonardi, MD, FAAD
  • Henry W. Lim, MD, FAAD - Handout
  • Linda F. Stein, MD, FAAD
  • Bruce Elliot Strober, MD, PhD, FAAD

Learning Objectives:
Following this course, the attendee should be able to:

  • Develop skills to manage patients with psoriasis and psoriatic arthritis with an emphasis on decision making criteria that will enable the clinician to individualize therapy based upon disease type, extent, response to previous treatments, quality of life issues, and co-morbidities.
  • Recognize and diagnose challenging clinical cases and formulate appropriate evidence-based treatment of patients using the recently published six AAD evidence-based guideline of care for psoriasis, which includes best practices.
  • Address gaps in clinical knowledge and care.

Description:
The session will be helpful in expanding physician knowledge base and improving clinical confidence and effectiveness in treating patients with psoriasis and psoriatic arthritis. The session will consist of six presentations with time available after each talk for interaction with the attendees. It will be structured in a question-and-answer format where case studies are discussed. To prepare participants, all attendees will be sent the AAD guidelines in advance so they have sufficient time to study before the session. A short survey will be conducted before and after the session, and follow-up survey will follow 6 months and a year later to gauge and evaluate if guidelines were easy to translate into daily clinical practice. Studies have shown that high-quality guidelines can make important contributions to improving medical care.

References:

  • Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 2008;58:826-50.
  • Gottlieb A, Korman NJ, Gordon KB, Feldman SR, Lebwohl M, Koo JY et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol 2008;58:851-64.
  • Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol 2009;60:643-59.

Schedule:

Sunday, March 23
2:00 PMIntroduction with Survey / Dr. Menter
2:05 PMBiosimilars in our Psoriasis Therapeutic Armamentarium: The Future / Dr. Menter
2:25 PMNew Developments in Psoriatic Arthritis / Dr. Gottlieb
2:45 PMTopical Therapy for Psoriasis with Case Study / Dr. Stein
3:00 PMPhototherapy for Psoriasis with Case Study / Dr. Lim
3:25 PMSystemic Therapy with Case Study / Dr. Lebwohl
3:50 PMBiologic Therapy with Case Study / Dr. Leonardi
4:15 PMPsoriasis Co-morbidities and Prevention of Risk Factors / Dr. Strober
4:40 PMPanel discussion with Survey / Dr. Menter